Latham & Watkins represented Spectrum Pharmaceuticals in the deal. Spectrum Pharmaceuticals, Inc. (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, has entered into...
Spectrum Pharmaceuticals’ $65 Million Debt Financing Agreement With SLR Capital Partners
AvidXchange’s $660.0 Million IPO
Paul Hastings advised AvidXchange Holdings, Inc. on the deal. AvidXchange Holdings, Inc., a leading provider of accounts payable and payment automation solutions for the middle market, priced...